I'm thinking until recently, that is when the Elixxia branding came to light, all was right with the world.
Cellucreme was going to be an instant company maker - a $3billion market according to POH, and provide sufficient funding for OXY trials.
Now I'm almost certain that "Cellucreme" is actually going to cost us money instead of bringing in the bacon.
I'm calling it a fumble but there's still time.
For now erring towards cautioun I have reduced my exposure in POH considerably.
financials have been released, page-26
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.551K | 580.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6575714 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 42608823 | 29 |
View Market Depth
| Last trade - 14.24pm 28/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |